An abbreviated version of the Brain Care Score predicts risk for dementia, stroke, and late-life depression based on lifestyle factors alone.

Glucagon-like peptide-1 receptor agonist therapy is associated with a reduced risk for epilepsy in adults with type 2 diabetes mellitus.

Suzanna's Kitchen breaded chicken has been recalled after soy, a major allergen, was not identified on the packaging.

New recommendations focused on psychological intervention may help manage or reduce the impact of functional seizures.

Among women with fibromyalgia, overactive bladder is prevalent and may often be associated with higher symptom severity and comorbidity.

The FDA has granted Fast Track designation to ST-503 for the treatment of small fiber neuropathy, a chronic neuropathic pain disorder.

The FDA has approved Uplizna for generalized myasthenia gravis in adults who are anti-AChR and anti-MuSK antibody positive.

Artificial intelligence-enabled point-of-care EEG allows rapid bedside seizure detection, accelerating treatment and preventing unnecessary care escalation.